Dmp1 shows its activity as a tumor suppressor by directly binding to the Arf promoter to activate its gene expression, and thereby induces p53-dependent cell cycle arrest [20], [21] (reviewed in [22], [23]). Here, CDKN2A is linked to neoplasm.